BIM
EW icon

Bridgecreek Investment Management’s Edwards Lifesciences EW Stock Holding History

Bridgecreek Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-144,610
Closed -$18.7M – 121
2021
Q4 		$18.7M Sell
144,610
-75
-0.1% -$8.75K 2.56% 12
2021
Q3 		$16.4M Sell
144,685
-605
-0.4% -$69.1K 2.34% 13
2021
Q2 		$15M Sell
145,290
-13,965
-9% -$1.32M 2.19% 15
2021
Q1 		$13.3M Sell
159,255
-1,410
-0.9% -$119K 2.06% 15
2020
Q4 		$14.7M Buy
160,665
+1,350
+0.8% +$112K 2.22% 16
2020
Q3 		$12.7M Buy
159,315
+120
+0.1% +$9.36K 2.23% 15
2020
Q2 		$11M Buy
159,195
+120
+0.1% +$8.53K 2.06% 15
2020
Q1 		$10M Buy
159,075
+3,975
+3% +$287K 2.59% 13
2019
Q4 		$12.1M Buy
155,100
+225
+0.1% +$17.6K 2.19% 12
2019
Q3 		$11.4M Buy
154,875
+1,140
+0.7% +$80.1K 2.36% 10
2019
Q2 		$9.47M Buy
153,735
+465
+0.3% +$28.1K 1.98% 15
2019
Q1 		$9.78M Buy
153,270
+2,655
+2% +$152K 2.07% 13
2018
Q4 		$7.69M Sell
150,615
-1,485
-1% -$75.1K 2.05% 14
2018
Q3 		$8.83M Buy
152,100
+630
+0.4% +$30.8K 1.76% 16
2018
Q2 		$7.35M Buy
151,470
+1,500
+1% +$70K 1.6% 22
2018
Q1 		$6.97M Buy
149,970
+3,075
+2% +$134K 1.57% 22
2017
Q4 		$5.52M Buy
146,895
+11,985
+9% +$440K 1.3% 31
2017
Q3 		$4.92M Buy
134,910
+8,025
+6% +$306K 1.34% 33
2017
Q2 		$5M Buy
126,885
+17,250
+16% +$630K 1.34% 36
2017
Q1 		$3.44M Buy
109,635
+32,100
+41% +$1M 0.93% 50
2016
Q4 		$2.42M Buy
+77,535
New +$2.51M 0.68% 57

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bridgecreek Investment Management's EW Position: Q1 2022 in Review

Bridgecreek Investment Management sold out of Edwards Lifesciences (EW) in Q1 2022, closing a stake of 144,610 shares — an estimated $18.7M sold.

Bridgecreek Investment Management first reported a position in EW in Q4 2016 and held it in 21 quarters. The position peaked at $18.7M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • Bridgecreek Investment Management reported no remaining Edwards Lifesciences position as of Q1 2022 after selling out during the quarter.
  • Bridgecreek Investment Management sold 144,610 Edwards Lifesciences shares in Q1 2022, an estimated $18.7M.
  • Bridgecreek Investment Management first reported a position in Edwards Lifesciences in Q4 2016 and held it in 21 quarters.
  • Bridgecreek Investment Management's Edwards Lifesciences position peaked at $18.7M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on Bridgecreek Investment Management's 13F filing for Q1 2022, filed 12 May 2022.